SCHEMBL4383618

SCHEMBL4383618

CC1CCC1(N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7592374 0.78
SCHEMBL2066341 0.76
SCHEMBL221041 0.76
Ammonia Solution, Strong SCHEMBL22553720 0.74 SLC6A4 (0.32)
Ammonia Solution, Strong SCHEMBL28561202 0.74 SLC6A4 (0.32)
SCHEMBL470456 0.73
SCHEMBL16271026 0.73
SCHEMBL4203556 0.72
SCHEMBL17103429 0.71
Ammonia Solution, Strong SCHEMBL28362490 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5665343-A POLYPHOSPHAZENE IL-YANG PHARM. CO., LTD (KR) 1997-09-09 US claimed
WO-2016193844-A1 NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME PFIZER INC. (US) 2016-12-08 WO disclosed
EP-1758907-B1 DIPHENYLIMIDAZOPYRIMIDINE AND -IMIDAZOLE AMINES AS INHIBITORS OF B-SECRETASE WYETH CORP (US) 2009-02-18 EP disclosed
US-20090042912-A1 DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE WYETH (US) 2009-02-12 US disclosed
US-7456186-B2 Diphenylimidazopyrimidines as inhibitors of β-secretase WYETH (US) 2008-11-25 US disclosed
EP-1758907-A1 DIPHENYLIMIDAZOPYRIMIDINE AND -IMIDAZOLE AMINES AS INHIBITORS OF B-SECRETASE Wyeth (US) 2007-03-07 EP disclosed
WO-2006009655-A1 DIPHENYLIMIDAZOPYRIMIDINE AND -IMIDAZOLE AMINES AS INHIBITORS OF B-SECRETASE WYETH (US) 2006-01-26 WO disclosed
US-20050282826-A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase WYETH (US) 2005-12-22 US disclosed